Brewers' final salvo for S&N?

S&N.jpg

The Heineken and Carlsberg consortium said they will not launch a hostile bid on Scottish & Newcastle after the UK brewer rejected its 780p per share proposal.

The consortium also urged the UK brewer's shareholders to call immediately on the S&N board of management to enter into substantive dialogue with the consortium. They wish to ensure a recommended offer before the 21 January deadline imposed by the UK's Takeover Panel.

It added that without a recommendation there will be no offer by the consortium and the proposal will lapse. S&N's continued refusal to accept the consortium's bid approaches, holding out for a higher bid, saw its shares rise another 9.5p, or 1.3%, in early trade to 728.5 pence.

S&N said earlier it has discussed with the consortium that it is prepared to engage with it, but only when a firm proposal of at least 800p a share has been made. It also demands Carlsberg publishes proper information about Baltic Beverages Holding's (BBH) prospects.

But the consortium said the S&N board's refusal to engage for its 780p proposal jeopardises significant value creation for S&N shareholders. Heineken and Carlsberg also said in a joint press release that the raised 780p per S&N share offer represents an implied equity value of £7.6 billion and an enterprise value of £10 billion.

'It is decision time for S&N shareholders. Without the S&N Board's co-operation there will be no offer by the consortium,' Heineken CEO Jean-François van Boxmeer said. But the consortium also said it reserves the right to proceed without a recommendation if an offer or possible offer for S&N is announced by a third party.

Carlsberg said it has confirmed to S&N that it is willing to provide the market with further financial disclosure on the current trading and prospects of its joint venture BBH, which Carlsberg operates on 50-50 basis with S&N.

Subject to the agreement of the BBH board, Carlsberg said it would be willing to either publish a 2007 profit estimate and forecast for 2008 or release a mutually agreed current trading and outlook statement for 2008-2010.

Other stories from :

FTSE 100FTSE100 Chart

Main Indices

Name Value Gain %
Nikkei 10,751.30 0.81
DAX 5,976.79 0.81
Dow J. 10,611.80 0.42
FTSE 100 5,633.43 0.29
FTSE 250 9,947.32 0.94
AIM 689.30 0.28
NASDAQ 2,368.46 0.00
Nikkei 10,751.26 0.81
Dow J. 0.00 0.00

Gainers / Losers

Name Value Gain %
Scientific D. O 21.00 31.25
Adalta Real Ord 5.00 25.00
Eatonfield Ord 2.23 21.92
Atlantic Global 18.50 19.35
West. & Orient. 2.38 18.75
Regen Therapeut 1.75 -17.65
Byotrol Ords 0. 22.75 -17.27
Northern Bear O 31.50 -14.86
Sceptre Ord 5p 42.50 -14.14

Never miss
an issue

51 Issues to your door

Digital online edition

Premier MoneyAM access

All for only £149
saving you over £100